rs1934614

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_172362.3(KCNH1):​c.1915+2638A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.255 in 152,106 control chromosomes in the GnomAD database, including 6,267 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.26 ( 6267 hom., cov: 32)

Consequence

KCNH1
NM_172362.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.362

Publications

2 publications found
Variant links:
Genes affected
KCNH1 (HGNC:6250): (potassium voltage-gated channel subfamily H member 1) Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium channel, voltage-gated, subfamily H. This member is a pore-forming (alpha) subunit of a voltage-gated non-inactivating delayed rectifier potassium channel. It is activated at the onset of myoblast differentiation. The gene is highly expressed in brain and in myoblasts. Overexpression of the gene may confer a growth advantage to cancer cells and favor tumor cell proliferation. Alternative splicing of this gene results in two transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]
KCNH1 Gene-Disease associations (from GenCC):
  • KCNH1 associated disorder
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Illumina
  • Temple-Baraitser syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
  • Zimmermann-Laband syndrome 1
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Zimmermann-Laband syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.459 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNH1NM_172362.3 linkc.1915+2638A>T intron_variant Intron 9 of 10 ENST00000271751.10 NP_758872.1 O95259-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNH1ENST00000271751.10 linkc.1915+2638A>T intron_variant Intron 9 of 10 2 NM_172362.3 ENSP00000271751.4 O95259-1

Frequencies

GnomAD3 genomes
AF:
0.255
AC:
38760
AN:
151988
Hom.:
6239
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.464
Gnomad AMI
AF:
0.0592
Gnomad AMR
AF:
0.219
Gnomad ASJ
AF:
0.165
Gnomad EAS
AF:
0.173
Gnomad SAS
AF:
0.143
Gnomad FIN
AF:
0.193
Gnomad MID
AF:
0.158
Gnomad NFE
AF:
0.168
Gnomad OTH
AF:
0.218
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.255
AC:
38851
AN:
152106
Hom.:
6267
Cov.:
32
AF XY:
0.252
AC XY:
18730
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.465
AC:
19271
AN:
41454
American (AMR)
AF:
0.220
AC:
3358
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.165
AC:
573
AN:
3470
East Asian (EAS)
AF:
0.173
AC:
897
AN:
5184
South Asian (SAS)
AF:
0.144
AC:
693
AN:
4814
European-Finnish (FIN)
AF:
0.193
AC:
2046
AN:
10588
Middle Eastern (MID)
AF:
0.163
AC:
48
AN:
294
European-Non Finnish (NFE)
AF:
0.168
AC:
11447
AN:
67992
Other (OTH)
AF:
0.219
AC:
464
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1384
2767
4151
5534
6918
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
358
716
1074
1432
1790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.214
Hom.:
532
Bravo
AF:
0.263
Asia WGS
AF:
0.196
AC:
684
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
3.8
DANN
Benign
0.43
PhyloP100
0.36
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1934614; hg19: chr1-210968212; COSMIC: COSV55106431; API